← Leaderboards
Kenneth A Matreyek
Case Western Reserve University
$3,168,000
Attributed
$3,168,000
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $644K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,168,000 · 4
By mechanism
R35$2,012,500 · 1
R21$885,500 · 2
K22$270,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Ashwini Sehgal$12,960,534
- Alan David Levine$25,871,674
- Anna Bruchez$885,500
Others in their field
Other Emerging Leaders on “Variant”
- Yunda Huang · Fred Hutchinson Cancer Center$63,914,632
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Theresa Engel · Leidos Biomedical Research, Inc.$44,839,860
- Scott Topper · Broad Institute, Inc.$40,042,399
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Evan Z Macosko · Broad Institute, Inc.$29,606,858
Research focus
VariantCellsComplexProteinsExperimental StudySynthetic BiologyGeneticMolecularAmino Acid SequenceLibrariesBiotechnologyResistanceReporterBar CodesBiologyPlayBiologicalHigh-Throughput Nucleotide SequencingInterestBindingFutureInsightInfectionVirus
Grant awards (11)
Recombinant DNA technologies for multiplex genetic assays in human cells$402,500
R35 · FY2025 · GM · contact PI
Recombinant DNA technologies for multiplex genetic assays in human cells$402,500
R35 · FY2024 · GM · contact PI
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes$201,250
R21 · FY2024 · AI · contact PI
Recombinant DNA technologies for multiplex genetic assays in human cells$402,500
R35 · FY2023 · GM · contact PI
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes$241,500
R21 · FY2023 · AI · contact PI
Recombinant DNA technologies for multiplex genetic assays in human cells$402,500
R35 · FY2022 · GM · contact PI
Multiplex discovery of synthetic host-protein combinations that inhibit HIV$241,500
R21 · FY2022 · AI · contact PI
Recombinant DNA technologies for multiplex genetic assays in human cells$402,500
R35 · FY2021 · GM · contact PI
Multiplex discovery of synthetic host-protein combinations that inhibit HIV$201,250
R21 · FY2021 · AI · contact PI
Massively Parallel Mutational Analyses of Viral Neutralization Mechanisms Against Human Restriction Factors$108,000
K22 · FY2020 · AI · contact PI
Massively Parallel Mutational Analyses of Viral Neutralization Mechanisms Against Human Restriction Factors$162,000
K22 · FY2019 · AI · contact PI